Journal
/
Cancer Research
/
Optimizing HCC Organoid Formation for Target Identification and Drug Development…
/
Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids (Video) | JoVE…
JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content.
Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids (Video) | JoVE
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/65785-v
•
01:28 min
•
August 18th, 2023
Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids (Video) | JoVE
Optimizing HCC Organoid Formation for Target Identification and Drug Development
August 18th, 2023
•
Cheng-Yang Zhang*1,2, Xiao-Feng Zhang*3, Jun Yuan*1,2, Yuan-Feng Gong4, Hui Tang4, Wan-Yu Guo1,2, Tong-Yan Li1,2, Cai-Wen Li1,2, Yun-Qiang Tang4, Ning-Fang Ma1,2, Ming Liu1,2
1Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University, 3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University
* These authors contributed equally